Side-by-side comparison.

Insufficient information

48.2% assessed

Limited evidence

Pharmacy license unverified

Insufficient information

45.2% assessed

Limited evidence

Pharmacy license unverified

The terms identify Eternum Health LLC, a New Jersey company doing business as Blue Haven RX. The official site publishes customer email and phone contacts; business registration was not independently checked.

The published terms identify Adonis Health, Inc. as the contracting platform operator and distinguish independent medical providers and pharmacies. The official site provides customer support contacts.

The terms name independent Wasef Health and Beluga Health professional entities, while the telehealth consent describes remote clinician review and prescribing only when appropriate. Individual clinician licenses were not matched.

The service describes healthcare-provider assessment and prescription fulfillment; individual credentials were not checked.

The reviewed site and privacy notice refer to pharmacy partners but do not identify the specific dispensing business or prescription destination.

Supply-chain evidence has not been sufficiently assessed.

No named dispensing pharmacy or active state-license match was established from the reviewed public pages; generic references to pharmacy partners do not qualify as registry verification.

No dispensing pharmacy and active state-license match has been verified.

No product- and lot-specific COA authenticated with its issuing independent laboratory was established from the public homepage and published terms reviewed. This is an evidence gap, not a failed laboratory test or a claim that no testing takes place.

No product- and lot-specific COA authenticated with its issuing independent laboratory was established from the public homepage and published terms reviewed. This is an evidence gap, not a failed laboratory test or a claim that no testing takes place.

Blue Haven RX's terms identify Eternum Health LLC, a New Jersey company, separately from its medical partners. Bounded FDA/FTC/DOJ searches using Blue Haven RX and Eternum Health did not establish an attributable enforcement decision or current court outcome on October 30, 2026. This is not a clean-record finding or an exhaustive state/court search.

Henry Meds' terms identify Adonis Health, Inc. dba Henry Meds, separately from clinical and pharmacy providers. Bounded FDA/FTC/DOJ searches using these names did not establish an attributable enforcement decision or current court outcome on October 30, 2026. Unrelated Adonis Health Care and Adonis Health Products results and FOIA request logs were excluded. This is not a clean-record finding or an exhaustive state/court search.

The home page advertises $149/month semaglutide and $179/month tirzepatide, but its FAQ lists $179 and $259 respectively. The page mentions a three-month introductory offer; it does not clearly reconcile each advertised price with plan length and later charges. Terms say final plan fees appear at checkout, which was not reviewed.

The program page lists charges and included items but is dated December 2025; a current individualized quote may differ.

The terms describe upfront billing, pre-authorization released if no prescription is approved, non-refundable charges after capture, and cancellation at least 48 hours before a renewal date that may occur up to 10 days before the term ends. Portal and email cancellation are described; no transaction or refund request was tested.

The terms describe renewal and cancellation, prescription final-sale restrictions, and refund deductions: a $30 consultation fee after a prescription is issued and a possible processing fee. Approval of a refund is conditional.

0 listed · 0 current state matches

Separate from the numerical benchmark; not a medical suitability decision.

0 listed · 0 current state matches

Separate from the numerical benchmark; not a medical suitability decision.